Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial

Authors not listed

Otsuka Pharmaceutical Development & Commercialization, Inc. · 2014

Abstract

To follow-up on the safety of subjects who were previously treated in a double-blind trial of brexpiprazole.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2014). A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial. <em>Otsuka Pharmaceutical Development & Commercialization, Inc.</em>. https://clinicaltrials.gov/study/NCT02192554
Vancouver
Anonymous. A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial. Otsuka Pharmaceutical Development & Commercialization, Inc.. 2014.
BibTeX
@misc{anon2014AMonth, title = {A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial}, author = {Anonymous}, journal = {Otsuka Pharmaceutical Development & Commercialization, Inc.}, year = {2014}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings